Two Versus One Week Breast Radiotherapy (RT)

This study is comparing two different radiation therapy approaches for early breast cancer to see which one is better for patients. One group will receive radiation over one week (based on the FAST-FORWARD trial), and the other group will receive radiation over two weeks with an extra focused dose (called a "concomitant boost"). The study will look at how the treatments affect side effects, breast appearance, and cancer control in the breast. It also aims to find out if the two-week treatment does a better job at preventing cancer from coming back in the breast over the long term.

Trial Details

NCT ID
NCT06960707
Phase
PHASE3
Sponsor
Weill Medical College of Cornell University
Status
RECRUITING
Cancer Type
Breast Cancer
Interventions
  • Radiation therapy - 1 week
  • Radiation therapy - 2 weeks
Locations (sample)
  • New York, New York, United States|40.71427,-74.00597
  • New York, New York, United States|40.71427,-74.00597
  • New York, New York, United States|40.71427,-74.00597

Key Eligibility Criteria

  • Women status post segmental mastectomy.
  • If unilateral, pT1-2 breast cancer excised with negative margins.
  • If bilateral, pT1-2 breast cancer excised with negative margins AND/OR pTis excised with negative margins.
  • Clinically N0 (cN0 as determined by ultrasound/SOUND criteria) or pN0-1 or Nx or sentinel node negative.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Breast Cancer Trials on Trialify →